Dr Karpouzas discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of...
In this podcast, Julian Bailes, MD, from NorthShore University HealthSystem, discusses traumatic brain injury, including mild traumatic brain injury and chronic traumatic encephalopathy.
In this podcast, Albert A. Rizzo, MD, chief medical officer of the ALA, explains what developments to expect from the $25 million COVID-19 Action Initiative.
In this podcast, Albert A. Rizzo, MD, chief medical officer of the ALA, explains what developments to expect from the $25 million COVID-19 Action Initiative.
In this podcast, Albert A. Rizzo, MD, chief medical officer of the ALA, explains what developments to expect from the $25 million COVID-19 Action Initiative.
In this podcast, Albert A. Rizzo, MD, chief medical officer of the ALA, explains what developments to expect from the $25 million COVID-19 Action Initiative.
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine...
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine...
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine...
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine...
